# Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period

> **NCT01900834** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 61 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Healthy

## Interventions

- **OTHER:** No treatment given

## Key facts

- **NCT ID:** NCT01900834
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2016-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01900834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01900834, "Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01900834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*